Skip to main content
Clinical Trials/NCT00920712
NCT00920712CompletedNot Applicable

Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis

Shanghai University of Traditional Chinese Medicine1 site in 1 country200 target enrollmentStarted: August 2009Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
200
Locations
1
Primary Endpoint
Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change

Study Overview

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Clinical diagnosis of Chronic Atrophic Gastritis
  • Male of female patients between 18-65 years old
  • Written informed consent

Exclusion Criteria

  • Combine with malignant pathology on epithelial dysplasia of gastric mucosa
  • Combine with duodenal ulcer or gastric ulcer
  • Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
  • Pregnancy or breast feeding women, or unwilling to have contraception.

Arms & Interventions

Weiqi decoction

Experimental

Intervention: Weiqi decotion (Drug)

low dose of Weiqi decoction

Placebo Comparator

Intervention: Weiqi decotion (Drug)

Outcomes

Primary Outcomes

Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change

Time Frame: 12 weeks

Secondary Outcomes

  • Indicates of liver and renal function(12 weeks)

Investigators

Sponsor
Shanghai University of Traditional Chinese Medicine
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Study of the Chinese Prescription Weiqi... | Clinical Trial